40 related articles for article (PubMed ID: 8182707)
21. Structure-activity relationships and modes of action of 9-anilinoacridines against chloroquine-resistant Plasmodium falciparum in vitro.
Chavalitshewinkoon P; Wilairat P; Gamage S; Denny W; Figgitt D; Ralph R
Antimicrob Agents Chemother; 1993 Mar; 37(3):403-6. PubMed ID: 8384810
[TBL] [Abstract][Full Text] [Related]
22. In vitro efficiency of 9-(N-cinnamoylbutyl)aminoacridines against blood- and liver-stage malaria parasites.
Pérez B; Teixeira C; Gomes AS; Albuquerque IS; Gut J; Rosenthal PJ; Prudêncio M; Gomes P
Bioorg Med Chem Lett; 2013 Feb; 23(3):610-3. PubMed ID: 23290049
[TBL] [Abstract][Full Text] [Related]
23. Antimalarial 9-anilinoacridine compounds directed at hematin.
Auparakkitanon S; Noonpakdee W; Ralph RK; Denny WA; Wilairat P
Antimicrob Agents Chemother; 2003 Dec; 47(12):3708-12. PubMed ID: 14638470
[TBL] [Abstract][Full Text] [Related]
24. Antimalarial acridines: synthesis, in vitro activity against P. falciparum and interaction with hematin.
Guetzoyan L; Yu XM; Ramiandrasoa F; Pethe S; Rogier C; Pradines B; Cresteil T; Perrée-Fauvet M; Mahy JP
Bioorg Med Chem; 2009 Dec; 17(23):8032-9. PubMed ID: 19879150
[TBL] [Abstract][Full Text] [Related]
25. 4,9-Diaminoacridines and 4-Aminoacridines as Dual-Stage Antiplasmodial Hits.
Fonte M; Tassi N; Fontinha D; Bouzón-Arnáiz I; Ferraz R; Araújo MJ; Fernàndez-Busquets X; Prudêncio M; Gomes P; Teixeira C
ChemMedChem; 2021 Mar; 16(5):788-792. PubMed ID: 33217195
[TBL] [Abstract][Full Text] [Related]
26. [Plasmodium protein-kinases and control of cellular proliferation: molecular targets for new antimalarial drugs].
Dorin D; Doerig C
Pathol Biol (Paris); 2002 May; 50(4):223-6. PubMed ID: 12085666
[No Abstract] [Full Text] [Related]
27. Synthesis and in vitro evaluation of 9-anilino-3,6-diaminoacridines active against a multidrug-resistant strain of the malaria parasite Plasmodium falciparum.
Gamage SA; Tepsiri N; Wilairat P; Wojcik SJ; Figgitt DP; Ralph RK; Denny WA
J Med Chem; 1994 May; 37(10):1486-94. PubMed ID: 8182707
[TBL] [Abstract][Full Text] [Related]
28. Plasmodium falciparum topoisomerases: Emerging targets for anti-malarial therapy.
Dar A; Godara P; Prusty D; Bashir M
Eur J Med Chem; 2024 Feb; 265():116056. PubMed ID: 38171145
[TBL] [Abstract][Full Text] [Related]
29. Receptor-mediated targeting of toxins to intraerythrocytic parasite Plasmodium falciparum. surolia@jncasr.ac.in.
Surolia N
Adv Drug Deliv Rev; 2000 Mar; 41(2):163-70. PubMed ID: 10699312
[TBL] [Abstract][Full Text] [Related]
30.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
31.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
